Канал: qcrc1

Wael AbdelAal

Wael AbdelAal

Michael Houlgate Yasser Sakr

Michael Houlgate Yasser Sakr

Ahmed El Guindy

Ahmed El Guindy

Mala Rao

Mala Rao

Magdi Ishak

Magdi Ishak

Somaya Hosny

Somaya Hosny

Rashad Barsoum

Rashad Barsoum

Magdi Yacoub

Magdi Yacoub

David Nicholson

David Nicholson

Maureen Baker

Maureen Baker

Gianluca Fontana

Gianluca Fontana

Hisham Dokainish - Interactive Cases with advanced HF (Imaging)

Hisham Dokainish - Interactive Cases with advanced HF (Imaging)

Heather Ross - Interactive HF cases management

Heather Ross - Interactive HF cases management

William J. McKenna - Role of genetics in management of cardiomyopathy

William J. McKenna - Role of genetics in management of cardiomyopathy

Nidal Asaad - Device therapy in heart failure

Nidal Asaad - Device therapy in heart failure

Magdi Yacoub - Device monitoring in Heart Failure

Magdi Yacoub - Device monitoring in Heart Failure

Heather Ross - Telemonitoring is the future of outpatient care for heart failure

Heather Ross - Telemonitoring is the future of outpatient care for heart failure

Hisham Dokainish - Echocardiography in diagnosis and prognosis of patients with heart failure

Hisham Dokainish - Echocardiography in diagnosis and prognosis of patients with heart failure

Amr Badr - Heart failure service up date (clinical research)

Amr Badr - Heart failure service up date (clinical research)

William McKenna and Magdi Yacoub - Opening Remarks

William McKenna and Magdi Yacoub - Opening Remarks

Leslie Miller - Stem cell and gene for heart failure: Are we ready for clinical use?

Leslie Miller - Stem cell and gene for heart failure: Are we ready for clinical use?

Faizzan Ahmad - IPS at QCRC

Faizzan Ahmad - IPS at QCRC

Magdi Yacoub (Christophe Raynaud) - Direct reprogramming at QCRC

Magdi Yacoub (Christophe Raynaud) - Direct reprogramming at QCRC

Yuan Tsan Tseng - Tissue engineering & designer scaffolds

Yuan Tsan Tseng - Tissue engineering & designer scaffolds

Leslie Miller - LVADs, evolution of indications

Leslie Miller - LVADs, evolution of indications

Magdi Yacoub - Bridge to Recovery, on the move.

Magdi Yacoub - Bridge to Recovery, on the move.

Nidal Asaad - Insights from Gulf CARE

Nidal Asaad - Insights from Gulf CARE

Haitham Abou Saleh - Role of Biomarkers, biochemical, micro particles

Haitham Abou Saleh - Role of Biomarkers, biochemical, micro particles

Shana Jacob - Proteomics and Lipidomics

Shana Jacob - Proteomics and Lipidomics

Despina Sanoudou - Micro RNA

Despina Sanoudou - Micro RNA

Nidal Asaad - Pacemakers and ICDs Lessons from the trials

Nidal Asaad - Pacemakers and ICDs Lessons from the trials

Robert Bonow - The Global Epidemic of HF

Robert Bonow - The Global Epidemic of HF

Leslie Miller - Risk stratification and prognostic indicators

Leslie Miller - Risk stratification and prognostic indicators

Amr Badr - INTER-CHF - Qatar

Amr Badr - INTER-CHF - Qatar

Martin Misfeld - Valve Conserving Operations - from Structure to Function

Martin Misfeld - Valve Conserving Operations - from Structure to Function

Magdi Yacoub - Taking Cardiac Surgery to the People

Magdi Yacoub - Taking Cardiac Surgery to the People

Ismail El Hamamsy - The Ross Procedure, a Clinical Perspective

Ismail El Hamamsy - The Ross Procedure, a Clinical Perspective

Dennis Cokkinos - Calcific aortic stenosis, Old and novel biomarkers

Dennis Cokkinos - Calcific aortic stenosis, Old and novel biomarkers

Karen Wooley - Stimuli-responsive, Polymer-based Technologies Derived from Natural Products

Karen Wooley - Stimuli-responsive, Polymer-based Technologies Derived from Natural Products

Katherine Yutzy - Division of Molecular Cardiovascular Biology

Katherine Yutzy - Division of Molecular Cardiovascular Biology

Remi Peyronnet - Mechanotransduction: from the whole heart to valves

Remi Peyronnet - Mechanotransduction: from the whole heart to valves

Jane Grande-Allen - In Vitro Models for Heart Valve Mechanobiology and Pathology

Jane Grande-Allen - In Vitro Models for Heart Valve Mechanobiology and Pathology

Peter Davies - Endothelial Phenotype Heterogeneity in an Unstable Hemodynamic Environment

Peter Davies - Endothelial Phenotype Heterogeneity in an Unstable Hemodynamic Environment

Lionel Jarvis and Magdi Yacoub - Opening Remarks

Lionel Jarvis and Magdi Yacoub - Opening Remarks

Peter Aziz - Is Genetic Analysis of Long QT Essential for Management?

Peter Aziz - Is Genetic Analysis of Long QT Essential for Management?

Thomas Zimmer - Clinical Utility of Basic Research

Thomas Zimmer - Clinical Utility of Basic Research

Panel discussion "Implantable defibrillators for whom and when?"

Panel discussion "Implantable defibrillators for whom and when?"

Magdi Yacoub - What have we learned and where do we go from here?

Magdi Yacoub - What have we learned and where do we go from here?

Thomas Zimmer - How do mutations translate into arrhythmias

Thomas Zimmer - How do mutations translate into arrhythmias

Peter Aziz - Relationship of Genotype to Phenotype in Long QT Syndrome

Peter Aziz - Relationship of Genotype to Phenotype in Long QT Syndrome

Christian Bollensdorff - Cellular Electrophysiology at QCRC

Christian Bollensdorff - Cellular Electrophysiology at QCRC

Josep Brugada - Brugada Syndrome: Risk Stratification

Josep Brugada - Brugada Syndrome: Risk Stratification

Nidal Asaad - Brugada Syndrome, Genetics preliminary result in the Gulf

Nidal Asaad - Brugada Syndrome, Genetics preliminary result in the Gulf

Thomas Zimmer - Role of Mutations in Different Na+ Channels

Thomas Zimmer - Role of Mutations in Different Na+ Channels

Peter Aziz - Genetics of Short QT Syndrome

Peter Aziz - Genetics of Short QT Syndrome

Josep Brugada - Channelopathies

Josep Brugada - Channelopathies

Salem Alkaabi - Brugada Syndrome in the Gulf

Salem Alkaabi - Brugada Syndrome in the Gulf

Peter Aziz - Epidemiology and Classification of Inherited Arrhythmias

Peter Aziz - Epidemiology and Classification of Inherited Arrhythmias

Josep Brugada - Brugada Syndrome

Josep Brugada - Brugada Syndrome

Discussion, questions and what have we learned?

Discussion, questions and what have we learned?

Discussion, questions and what have we learned?

Discussion, questions and what have we learned?

Lionel Jarvis and Robert Bonow - Opening Remarks and Seminar Objectives

Lionel Jarvis and Robert Bonow - Opening Remarks and Seminar Objectives

Frederick Han, Nassir Marrouche - Substrate Guided AF Management

Frederick Han, Nassir Marrouche - Substrate Guided AF Management

Nidal Asaad - The Doha Experience with AF Treatment, Catheter Ablations and Other Arrythmias

Nidal Asaad - The Doha Experience with AF Treatment, Catheter Ablations and Other Arrythmias

Dawood Darbar - Rate vs. Rhythm Control Therapy for Atrial Fibrillation

Dawood Darbar - Rate vs. Rhythm Control Therapy for Atrial Fibrillation

Bob Bonow - Atrial Fibrillation: Evidence-Based New Choices for Oral Anticoagulation

Bob Bonow - Atrial Fibrillation: Evidence-Based New Choices for Oral Anticoagulation

Riyaz Kaba - Is Obesity Driving the Surge in AF?

Riyaz Kaba - Is Obesity Driving the Surge in AF?

Iacopo Olivotto - Atrial Fibrillation in Inherited Heart Muscle Disease

Iacopo Olivotto - Atrial Fibrillation in Inherited Heart Muscle Disease

Sabine Ernst - Novel Approaches to Catheter Ablation

Sabine Ernst - Novel Approaches to Catheter Ablation

Magdi Yacoub - The Maze Operation

Magdi Yacoub - The Maze Operation

QHSS Management and Tips. Discussion, questions and what have we learned?

QHSS Management and Tips. Discussion, questions and what have we learned?

James Kirklin - The future of Mechanical Circulatory Support, what can we expect?

James Kirklin - The future of Mechanical Circulatory Support, what can we expect?

Robert Bonow - Staging of heart failure

Robert Bonow - Staging of heart failure

QHSS Evolving Indications. Discussion, questions and what have we learned?

QHSS Evolving Indications. Discussion, questions and what have we learned?

Mohammed Al Hashemi - Rehabilitation programme; the Qatar experience

Mohammed Al Hashemi - Rehabilitation programme; the Qatar experience

Abdulaziz Al Khulaifi - Contemporary Ventricular Assist Devices

Abdulaziz Al Khulaifi - Contemporary Ventricular Assist Devices

James Kirklin - Clinical trials of LVADs; current and future

James Kirklin - Clinical trials of LVADs; current and future

Magdi Yacoub - Combination therapy and bridge to recovery

Magdi Yacoub - Combination therapy and bridge to recovery

Haitham Abou-Saleh - The potential value of biomarkers

Haitham Abou-Saleh - The potential value of biomarkers

Despina Sanoudou - Genetic testing in DCM; the QCRC programme.

Despina Sanoudou - Genetic testing in DCM; the QCRC programme.

Magdi Yacoub and Lionel Jarvis - Opening remarks and seminar objectives

Magdi Yacoub and Lionel Jarvis - Opening remarks and seminar objectives

Amr Badr - Heart failure in Qatar

Amr Badr - Heart failure in Qatar

James Kirklin - The INTERMACS. Grading, rationale and utility.

James Kirklin - The INTERMACS. Grading, rationale and utility.

Abdurrazzak Gehani - Designing a National Programme for PCI in Qatar

Abdurrazzak Gehani - Designing a National Programme for PCI in Qatar

Mohamed Sobhy - Stent for Life Program in Egypt

Mohamed Sobhy - Stent for Life Program in Egypt

Amr ElFaramawy - Primary PCI; The Evolving Program in Aswan

Amr ElFaramawy - Primary PCI; The Evolving Program in Aswan

David Antioniucci - Rheolytic Therapy and Thrombus Aspiration: What is the Evidence?

David Antioniucci - Rheolytic Therapy and Thrombus Aspiration: What is the Evidence?

David Antoniucci - Setting Up a Primary PCI Service

David Antoniucci - Setting Up a Primary PCI Service

Carlo Di Mario - Stent for Life Programme

Carlo Di Mario - Stent for Life Programme

Roxy Senior - Beyond Epicardial Coronaries: Role of the Microcirculation, Non-Invasive Measurements

Roxy Senior - Beyond Epicardial Coronaries: Role of the Microcirculation, Non-Invasive Measurements

Peter Wilson - Lipid Therapy in 2013

Peter Wilson - Lipid Therapy in 2013

Magdi Yacoub - Biomarkers: What's New?

Magdi Yacoub - Biomarkers: What's New?

Carlo DiMario - IVUS and OCT: Ready for Routine Use?

Carlo DiMario - IVUS and OCT: Ready for Routine Use?

Robert Bonow - Algorithms for Management and Risk Stratification

Robert Bonow - Algorithms for Management and Risk Stratification

Robert Bonow - Designing Strategies for Imaging

Robert Bonow - Designing Strategies for Imaging

Attilio Maseri - The Revival of Clinical Research

Attilio Maseri - The Revival of Clinical Research

Ahmed El Guindy - Beyond Epicardial Coronaries: Role of the Microcirculation, Invasive Assessment

Ahmed El Guindy - Beyond Epicardial Coronaries: Role of the Microcirculation, Invasive Assessment

Raad Mohiaddin - Imaging Beyond the Lumen into the Arterial Wall

Raad Mohiaddin - Imaging Beyond the Lumen into the Arterial Wall

Adrian Chester - Mechanobiology of Atherosclerosis

Adrian Chester - Mechanobiology of Atherosclerosis

Ashraf Reda - Lipidology

Ashraf Reda - Lipidology

Magdy Rashwan - Plaque Characterisation

Magdy Rashwan - Plaque Characterisation

Mohmed Sobhy - Acute coronary syndrome: access registry

Mohmed Sobhy - Acute coronary syndrome: access registry

Erling Falk - Plague Rupture is the ONLY Culprit

Erling Falk - Plague Rupture is the ONLY Culprit

Andrew Newby - Atherothrombosis and inflammation

Andrew Newby - Atherothrombosis and inflammation

Peter Wilson - Framingham at Fifty: What Have We Learned?

Peter Wilson - Framingham at Fifty: What Have We Learned?

Elio Riboli - Population Biobanks: scientific platforms for investigation

Elio Riboli - Population Biobanks: scientific platforms for investigation

Peter Wilson - Diabetes Mellitus, Insulin Resistance and ACS

Peter Wilson - Diabetes Mellitus, Insulin Resistance and ACS

Jasper Kooner - The LOLIPOP Study: Insights into Ethnicity

Jasper Kooner - The LOLIPOP Study: Insights into Ethnicity

J Tardiff - Cardiomyopathies associated troponin mutations: are they different?

J Tardiff - Cardiomyopathies associated troponin mutations: are they different?

C Rapezzi - An overview on how to improve diagnosis and prognosis of restrictive cardiomyopathies

C Rapezzi - An overview on how to improve diagnosis and prognosis of restrictive cardiomyopathies

B Marron - Lessons learned from four decades of surgical myectomy

B Marron - Lessons learned from four decades of surgical myectomy

P Camici Pathophysiology of pf coronary microvascular dysfunction in primary and secondary LVH

P Camici Pathophysiology of pf coronary microvascular dysfunction in primary and secondary LVH

R Bonow USA, Europe and the Rest of the World, differences and similarities

R Bonow USA, Europe and the Rest of the World, differences and similarities

I Olivotto Pharmacological Treatment High Time for Evidence

I Olivotto Pharmacological Treatment High Time for Evidence

G Thiene Lesson from History, Galileo as a patient

G Thiene Lesson from History, Galileo as a patient

T B Rasmussen - The majority of plakophilin-2 mutations in ARVC are associated...

T B Rasmussen - The majority of plakophilin-2 mutations in ARVC are associated...

M Imazio - Diagnosis and management of pericardial diseases

M Imazio - Diagnosis and management of pericardial diseases

I Olivotto - Management of HCM: the case for disease staging

I Olivotto - Management of HCM: the case for disease staging

G Limongelli - Step by step approach to cardiomyopathies in children

G Limongelli - Step by step approach to cardiomyopathies in children

C Ferrara - The HCM-associated cardiac Troponin T mutation K280N

C Ferrara - The HCM-associated cardiac Troponin T mutation K280N

B Stauffer - Unique myocardial molecular remodelling in children with heart failure

B Stauffer - Unique myocardial molecular remodelling in children with heart failure

P G Masci Interstitial myocardial fibrosis detected by cardiovascular MRI as a subclinical marker of cardiac involvement in Imna mutation carriers

P G Masci Interstitial myocardial fibrosis detected by cardiovascular MRI as a subclinical marker of cardiac involvement in Imna mutation carriers

B Marron Are we making good use of cardiac MRI in clinical practice

B Marron Are we making good use of cardiac MRI in clinical practice

L Mestroni Genotyping and clinical management of DCM

L Mestroni Genotyping and clinical management of DCM

N Frey Role of protein degragation pathways in the pathogenesis of cardiomyopathy

N Frey Role of protein degragation pathways in the pathogenesis of cardiomyopathy

M Yacoub - Mechanisms and implications of myocardial recovery in LVAD patients

M Yacoub - Mechanisms and implications of myocardial recovery in LVAD patients

K van Spaendonck Zwarts Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy

K van Spaendonck Zwarts Genetic analysis in 418 index patients with idiopathic dilated cardiomyopathy

A Mazzanti A mutation site approach helps predicting the phenotype expression of MYH7 mutations

A Mazzanti A mutation site approach helps predicting the phenotype expression of MYH7 mutations

L Choudhury Association of LV wall thickness and myocardial fibrosis scar with adverse events in HCM

L Choudhury Association of LV wall thickness and myocardial fibrosis scar with adverse events in HCM

E Biagini Genetic profile of HCM patients with LV systolic dysfunction, a multicenter study

M G Bongiorni Individualised choice, prevention and managementof ICD related to complication

M G Bongiorni Individualised choice, prevention and managementof ICD related to complication

L Monserrat Next generation genotyping, from diagnosis to prognosis

L Monserrat Next generation genotyping, from diagnosis to prognosis

I Olivotto Ranolazine in chronic ischemic cardiomyopathy, benifits for the quality of life

I Olivotto Ranolazine in chronic ischemic cardiomyopathy, benifits for the quality of life

F Girolami Changing Scenarios with next generation sequencing

F Girolami Changing Scenarios with next generation sequencing

F Cecchi HCM, defining risk and the high risk pt the dilemma od ICD in primary prevention

F Cecchi HCM, defining risk and the high risk pt the dilemma od ICD in primary prevention

P.Elliott - Classification of Cardiomyopathies: News for the Future

P.Elliott - Classification of Cardiomyopathies: News for the Future

Alkordi Presentation AHC June 2010 Short

Alkordi Presentation AHC June 2010 Short

Where do we go from here? - Magdi Yacoub

Where do we go from here? - Magdi Yacoub

Innovative research, Renal Denervation -- Carlo Di Mario

Innovative research, Renal Denervation -- Carlo Di Mario

Surgery is Superior to PCI; lessons from the trials - David Taggart

Surgery is Superior to PCI; lessons from the trials - David Taggart

Current Guidelines - Robert Bonow

Current Guidelines - Robert Bonow

FFR & IFR in decision making, current and future - Carlo Di Mario

FFR & IFR in decision making, current and future - Carlo Di Mario

Abdulwahid Al Mulla - Aortic Valve Replacement at Hamad Hospital

Abdulwahid Al Mulla - Aortic Valve Replacement at Hamad Hospital

Rheumatic Heart Disease - Group Discussion

Rheumatic Heart Disease - Group Discussion

Ryo Torii - In Vivo Measurement of Flow Dynamics and Aortic Wall Shear Stress

Ryo Torii - In Vivo Measurement of Flow Dynamics and Aortic Wall Shear Stress

Magdi Yacoub - The Living Aortic Root

Magdi Yacoub - The Living Aortic Root

Susy Kotit - Epidemiology of Rheumatic Heart Disease in Aswan

Susy Kotit - Epidemiology of Rheumatic Heart Disease in Aswan

Carlo Di Mario - TAVI; Current and Future

Carlo Di Mario - TAVI; Current and Future

Robert Bonow - Global Burden of RHD

Robert Bonow - Global Burden of RHD

Robert Bonow - Guidelines for Aortic Valve Replacement; an International Perspective

Robert Bonow - Guidelines for Aortic Valve Replacement; an International Perspective

Ahmed Al-Motarreb - Rheumatic Heart Disease in Yemen

Ahmed Al-Motarreb - Rheumatic Heart Disease in Yemen

Welcome Address - Abdulwahid Al Mulla and Magdi Yacoub

Welcome Address - Abdulwahid Al Mulla and Magdi Yacoub

Thomas Brand - Heart Valve development; the Role of Genetics and Biomechanics

Sherif Helmy - Non-Invasive Pre-operative Assessment of the Aortic Valve

Sherif Helmy - Non-Invasive Pre-operative Assessment of the Aortic Valve

Magdi Yacoub - The Bicuspid Aortic Valve from Science to Practice

Magdi Yacoub - The Bicuspid Aortic Valve from Science to Practice

Navaneeth Krishnamoorthy - Designer Collagen Mimetic Peptide Scaffolds for Tissue Engineering

Navaneeth Krishnamoorthy - Designer Collagen Mimetic Peptide Scaffolds for Tissue Engineering

David Taggart - Lessons from the SYNTAX trial.

David Taggart - Lessons from the SYNTAX trial.

Carlo Di Mario - Surgery is Superior to PCI; lessons from the trials.

Carlo Di Mario - Surgery is Superior to PCI; lessons from the trials.

Abdurrazak Gehani - The evolving QCRC national programme, progress to date.

Abdurrazak Gehani - The evolving QCRC national programme, progress to date.

Carlo Di Mario - Stent for life programme.

Carlo Di Mario - Stent for life programme.

Carlo Di Mario - Innovative research, Renal Denervation.

Carlo Di Mario - Innovative research, Renal Denervation.

Carlo Di Mario - Innovative research, Renal Denervation.

Carlo Di Mario - Innovative research, Renal Denervation.

Carlo Di Mario - Stent for life programme.

Carlo Di Mario - Stent for life programme.

Question and Answers.

Question and Answers.

Abdurrazak Gehani - The evolving QCRC national programme, progress to date.

Abdurrazak Gehani - The evolving QCRC national programme, progress to date.

David Taggart - Surgery is Superior to PCI; lessons from the trials.

David Taggart - Surgery is Superior to PCI; lessons from the trials.

Carlo Di Mario - Surgery is Superior to PCI; lessons from the trials.

Carlo Di Mario - Surgery is Superior to PCI; lessons from the trials.

Iacopo Olivotto.

Iacopo Olivotto.

David Taggart - Lessons from the SYNTAX Trial.

David Taggart - Lessons from the SYNTAX Trial.

Magdi Yacoub - QCRC and knowledge dissemination.

Magdi Yacoub - QCRC and knowledge dissemination.

Abdulwahid Al Mulla - Welcome and Seminar Objectives.

Abdulwahid Al Mulla - Welcome and Seminar Objectives.